Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)
NIH supports themed digestive and liver disease research centers that provide shared resources and foster collaboration among basic and clinical investigators; clinical trials are optional.
Funder: National Institutes of Health
Due Dates: September 29, 2026 (Applications) | February 10, 2027 (Applications)
Funding Amounts: Up to $750,000 in direct costs per year for up to five years
Summary: Supports shared research cores and collaborative programs advancing digestive and liver disease research within NIDDK’s mission.
Key Information: Institutions need an existing research base of at least $3 million annually in direct costs, with at least 30% from NIDDK.
Description
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) supports Digestive Diseases Research Core Centers through the NIH P30 mechanism. Centers bring together basic and clinical investigators to improve communication, collaboration, and the effectiveness of ongoing digestive and liver disease research. Funding supports cost-effective shared resources that increase productivity, encourage scientific exchange, and generate new research ideas.
Each Center must have a cohesive central theme within NIDDK’s primary mission, rather than a thematic area primarily funded by another NIH institute or center. The program combines biomedical research cores, administration, a Scientific Catalyst Program, and pilot and feasibility studies. Its goal is to improve understanding of disease mechanisms and advance prevention, diagnosis, and treatment. Applications may include clinical trials, but trials are not required.
